Welcome to the Idaho Chapter of the American College of Cardiology
| Alina Robert, MD, FACC
Chapter President
|
| Robert Duerr, MD, FACC
Incoming Governor
|
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- Long-Term Obesity May Accelerate Aging in Young AdultsLong-term obesity was associated with markers of accelerated biological aging in adults aged 28-31 years, according to a multiple-events, case-control study published in JAMA Network Open.
- Anomalous Aortic Origin of the Coronary ArteryAnomalous aortic origin of the coronary arteries (AAOCA) is a rare congenital heart condition that represents the second leading cause of sudden cardiac death (SCD) in young athletes.
- BRIDGE-TNK: Tenecteplase Before Thrombectomy Improves Post Stroke Functional OutcomesIntravenous tenecteplase before endovascular thrombectomy improves functional independence among patients with acute ischemic stroke due to large-vessel occlusion (LVO) presenting within 4.5 hours vs. thrombectomy alone, according to new results from the BRIDGE-TNK randomized trial...
- Decline in Health Status, Higher Mortality Rates Among US Children vs. Comparable CountriesThe health of children in the U.S. has worsened over the past 17 years, across multiple domains, including child mortality, chronic conditions, obesity, functional status and symptoms, according to a recent study published in JAMA.
- Single-Pill Combination Therapy Could Prevent Up to 72 Million CVD Deaths By 2050Single-pill combination (SPC) therapies, consisting of a statin and one or more antihypertensive drugs with or without aspirin, could potentially prevent up to 72 million deaths from cardiovascular disease and 130 million cases of cardiovascular disease in an intermediate-to-high risk population by 2050...